Compound EN300-7374549(BB)

CAS No. 66036-77-9

Compound EN300-7374549(BB)( N'-Nitro-D-arginine | (R)-2-Amino-5-(3-nitroguanidino)pentanoic acid | H-D-Arg(NO2)-OH )

Catalog No. M28746 CAS No. 66036-77-9

Compound EN300-7374549(BB) is a Building Block.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Compound EN300-7374549(BB)
  • Note
    Research use only, not for human use.
  • Brief Description
    Compound EN300-7374549(BB) is a Building Block.
  • Description
    Compound EN300-7374549(BB) is a Building Block.
  • In Vitro
    ——
  • In Vivo
    N'-Nitro-D-arginine (40 mg/kg) produces a significant increase in systolic blood pressure in the chronic, awake, instrumented sheep model.
  • Synonyms
    N'-Nitro-D-arginine | (R)-2-Amino-5-(3-nitroguanidino)pentanoic acid | H-D-Arg(NO2)-OH
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Nicotinic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    66036-77-9
  • Formula Weight
    219.201
  • Molecular Formula
    C6H13N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N[C@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cordi A, et al. Synthesis of 1,2-diacyl-3-nicotinoyl glycerol derivatives and evaluation of their acute effects on plasma lipids in the rat. Arzneimittelforschung. 1995 Sep;45(9):997-1001.
molnova catalog
related products
  • alpha-Tocopherolquin...

    During hypoxia in rats, levels of α-tocopherylquinon have been found to rise. It is reported to downregulate the respiratory activity of mitochondria.

  • WAY-659694

    WAY-659694 shows moderate acute anti-inflammatory activity and analgesic activity in vivo.

  • Eugeniin

    Tellimagrandin II (Eugeniin), with oral activity, is the first intermediate of the ellagitannin series derived from 4C1-glucose. It inhibits the resistance of Staphylococcus aureus by disrupting the integrity of the cell wall, leading to the loss of cytoplasmic contents. Additionally, Tellimagrandin II exhibits anti-inflammatory effects and inhibits acetylcholinesterase (AChE) activity, improving memory impairment. Tellimagrandin II holds potential for research in the fields of antibacterial, anti-inflammatory, and neurodegenerative diseases.